InvestorsObserver
×
News Home

Will ENDRA Life Sciences Inc (NDRA) Stay at the Top of the Healthcare Sector?

Tuesday, November 16, 2021 02:57 PM | InvestorsObserver Analysts

Mentioned in this article

Will ENDRA Life Sciences Inc (NDRA) Stay at the Top of the Healthcare Sector?

ENDRA Life Sciences Inc (NDRA) is around the top of the Healthcare sector according to InvestorsObserver. NDRA received an overall rating of 32, which means that it scores higher than 32% of stocks. Additionally, ENDRA Life Sciences Inc scored a 70 in the Healthcare sector, ranking it higher than 70% of stocks in that sector.

Overall Score - 32
NDRA has an Overall Score of 32. Find out what this means to you and get the rest of the rankings on NDRA!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies in the healthcare sector can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the best stocks in that sector. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With ENDRA Life Sciences Inc Stock Today?

ENDRA Life Sciences Inc (NDRA) stock has fallen -14.35% while the S&P 500 has risen 0.58% as of 2:53 PM on Tuesday, Nov 16. NDRA is lower by -$0.19 from the previous closing price of $1.33 on volume of 969,056 shares. Over the past year the S&P 500 is higher by 29.86% while NDRA has risen 40.74%. NDRA lost -$0.71 per share the over the last 12 months. Click Here to get the full Stock Report for ENDRA Life Sciences Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App